Benitec Biopharma Inc.
BNTC
$11.94
-$0.23-1.89%
| Weiss Ratings | BNTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | BNTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BNTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.65 | |||
| Price History | BNTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.67% | |||
| 30-Day Total Return | 4.65% | |||
| 60-Day Total Return | 15.03% | |||
| 90-Day Total Return | 22.71% | |||
| Year to Date Total Return | -1.16% | |||
| 1-Year Total Return | 99.33% | |||
| 2-Year Total Return | 219.98% | |||
| 3-Year Total Return | -64.88% | |||
| 5-Year Total Return | -89.62% | |||
| 52-Week High % Change | -27.99% | |||
| 52-Week Low % Change | 156.21% | |||
| Price | BNTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $16.90 | |||
| 52-Week Low Price | $4.75 | |||
| 52-Week Low Price (Date) | Apr 16, 2024 | |||
| 52-Week High Price (Date) | Mar 21, 2025 | |||
| Valuation | BNTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 310.27M | |||
| Enterprise Value | 232.12M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -3.04 | |||
| Earnings Per Share Growth | -72.79% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 3.76 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $11.94 | |||
| Enterprise Value/EBITDA (TTM) | -9.67 | |||
| Enterprise Value/EBIT | -9.64 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | BNTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 22.08M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $0.70 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $0.70 | |||
| Company Info | BNTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 510 780 0819 | |||
| Address | 3940 Trust Way Hayward, CA 94545 | |||
| Website | benitec.com | |||
| Country | United States | |||
| Year Founded | 1995 | |||
| Profitability | BNTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | BNTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -29.99% | |||
| Return on Equity | -- | |||
| Income Statement | BNTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 3.00K | |||
| EBITDA (TTM) | -24.00M | |||
| EBIT (TTM) | -24.09M | |||
| Net Income (TTM) | -21.42M | |||
| Net Income Avl. to Common (TTM) | -21.42M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -8.22% | |||
| EPS Diluted (TTM) | -3.04 | |||
| EPS Diluted Growth (Q YOY) | 87.37% | |||
| Balance Sheet | BNTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 78.28M | |||
| Cash Per Share (Q) | $3.55 | |||
| Total Current Assets (Q) | 78.71M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 75.94M | |||
| Current Ratio (Q) | 25.482 | |||
| Book Value Per Share (Q) | $3.24 | |||
| Total Assets (Q) | 79.07M | |||
| Total Current Liabilities (Q) | 3.09M | |||
| Total Debt (Q) | 137.00K | |||
| Total Liabilities (Q) | 3.13M | |||
| Total Common Equity (Q) | 75.94M | |||
| Cash Flow | BNTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -191.00K | |||
| Cash from Financing (TTM) | 79.60M | |||
| Net Change in Cash (TTM) | 57.96M | |||
| Levered Free Cash Flow (TTM) | -15.39M | |||
| Cash from Operations (TTM) | -21.75M | |||
